Philips Delivers On Aim To Focus Exclusively On Health And Healthtech

Jan 29 2020

• By Ashley Yeo

Listen to this article

Royal Philips is planning to sell its domestic appliance business to better focus on its strategic aims in health technology. The group made the announcement as it unveiled 2019 sales up 4.5% on a comparable basis.

Philips

In the past eight years, Philips Healthcare has transformed from a group that made 50% of its sales in health-care businesses in 2011, to 98% in 2019. At the group’s fiscal 2019 results, where comparable annual sales growth of 4.5% to €19.48bn ($21.46bn) was announced, the scale of the transformation was evident: Philips’ focus is now on diagnostic care and treatment (44% of sales), connected care (24%) and personal care (30%). Gone are the lighting, consumer electronics and TV businesses, and soon to follow will be domestic appliances.

The domestic appliances divestment has not been unexpected. Announcing the rationale behind the decision on 28 January, group CEO Frans...

More from Asia

Global Medtech Guidance Tracker: September 2024
Oct 02 2024
• By Vibha Sharma
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Over 40 documents have been posted on the tracker since its last update.
J&J MedTech Keeps Up Cardiovascular Momentum With Shockwave E8 Launch In US
Sep 25 2024
Tim Schmid, executive VP and worldwide chairman of J&J MedTech, expects Shockwave, acquired in April, and Abiomed, purchased in late 2022, to be “long-term gems” for the company. Cardiovascular is among higher-growth segments where J&J has concentrated investments in recent years, along with robotic surgical systems.
Pilot To Program: FDA Issues Accreditation Scheme For Conformity Assessment Draft Guidances
Sep 25 2024
• By Brian Bossetta
The US FDA has published a trio of draft guidance documents for its Assessment Scheme for Conformity Program, which began as a pilot in September 2020 to capitalize on the role of standards in the regulation of medical devices.
Global Medtech Guidance Tracker: August 2024
Sep 03 2024
• By Vibha Sharma
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Nearly 80 documents have been posted on the tracker since its last update.

More from Geography

Pilot To Program: FDA Issues Accreditation Scheme For Conformity Assessment Draft Guidances
Sep 25 2024
• By Brian Bossetta
The US FDA has published a trio of draft guidance documents for its Assessment Scheme for Conformity Program, which began as a pilot in September 2020 to capitalize on the role of standards in the regulation of medical devices.
Biocomposites Fully Acquires SYNICEM And Subiton Lines, Launches NanoBone In UK
Sep 18 2024
• By Natasha Barrow
UK-based Biocomposites will begin selling in the UK its next-generation osteoinductive bone graft substitute, NanoBone, which came with its acquisition of Artoss GmbH in June 2023. Meanwhile, the company has purchased remaining shares in the manufacturers of SYNICEM and Subiton antibiotic bone cements and preformed antibiotic-loaded spacers.
Senseonics Readies For US Launch Of 'World’s First One-Year CGM'
Sep 17 2024
• By Natasha Barrow
US FDA has greenlighted Senseonics’ Eversense 365 continuous glucose monitor, which must be replaced just once a year. Capable of being integrated with compatible insulin pumps as part of an automated insulin delivery system, the fully implantable device lasts 185 days longer than the Eversense E3 sensor and far outstrips competing CGMs, which last only for 10-14 days.